DavidSBoyerMD

Ophthalmology • Los Angeles, CA

Retinal Disease, Uveitis, Ocular Oncology

Clinical Professor of Ophthalmology, USC School of Medicine

Join to view full profile

Dr. Boyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Boyer's full profile

Already have an account?

Office
1245 Wilshire Blvd
Ste 380
Los Angeles, CA 90017
Phone+1 213-483-8810

Fax+1 213-975-9118

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1976 - 1977
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 1973 - 1976
University of Southern California/LACUSC Medical CenterInternship, Transitional Year, 1972 - 1973
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1972

Certifications & Licensure

CA State Medical License 1973 - 2027
HI State Medical License Active through 2014
PA State Medical License 1976 - 1978
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Top Doctors:LA Area Castle Connolly, 2013
Top Doctors:Southern California Castle Connolly, 2012
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FAAO) American Academy of Ophthalmology
Join now to see all

Clinical Trials

Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study Start of enrollment: 2010 Feb 01
Completed
Phase 2
Seven Year Update of Macular Degeneration Patients Start of enrollment: 2010 Dec 01
Completed
Pilot Study of X-82 in Patients With Wet AMD Start of enrollment: 2012 Oct 01
Completed
Phase 1, Phase 2
A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema Start of enrollment: 2013 Nov 01
Completed
Phase 1, Phase 2
A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment Start of enrollment: 2013 Oct 01
Completed
Phase 1
Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
Completed
A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME) Start of enrollment: 2014 Oct 01
Completed
Phase 1
A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion Start of enrollment: 2014 Feb 01
Completed
Phase 2
A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME Start of enrollment: 2014 Jul 18
Completed
Phase 1
Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema Start of enrollment: 2014 Jul 01
Completed
Not Applicable
Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration Start of enrollment: 2015 Apr 01
ACTIVE_NOT_RECRUITING
PHASE1, PHASE2
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD Start of enrollment: 2015 Jul 01
Completed
Phase 1
Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa Start of enrollment: 2017 Mar 01
Completed
Phase 2
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III) Start of enrollment: 2019 Sep 01
Active, not recruiting
Not Applicable
HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia Start of enrollment: 2020 Jun 12
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Longitudinal Changes in Diabetic Retinopathy Severity: Learnings from PANORAMA.
Charles C Wykoff, Diana V Do, W Lloyd Clark, David S Boyer, Dilsher S Dhoot
Ophthalmology. Retina. 2025-01-01
Phase 1b Dose Escalation Study of Sozinibercept Inhibition of Vascular Endothelial Growth Factors C and D With Aflibercept for Diabetic Macular Edema.
David S Boyer, Nathan C Steinle, Joel A Pearlman, Cameron M Stone, Courtney Crawford
Translational Vision Science & Technology. 2024-12-02
2 citations
Reply.
David S Boyer, Marion R Munk, Stephanie E Tedford, Cindy L Croissant, Rene Rückert
Retina. 2024-12-01

Press Mentions

Light Therapy Might Help Ease 'Dry' Form of Macular DegenerationOctober 22nd, 2024
Oculis Announces Positive Top Line Results from DIAMOND Stage 1 Phase 3 Trial in Diabetic Macular Edema with OCS-01 Eye DropsMay 22nd, 2023
Nanoscope Therapeutics Announces FDA Clearance of IND for MCO-010 Gene Therapy in Stargardt Macular Degeneration PatientsJanuary 25th, 2022
Join now to see all